What is the current market valuation of the UK singleplex immunoassay market?

The market valuation was $14.78 Million in 2024. Read More

What is the projected market size for the UK singleplex immunoassay market by 2035?

The projected valuation for 2035 is $20.85 Million. Read More

What is the expected CAGR for the UK singleplex immunoassay market during the forecast period 2025 - 2035?

The expected CAGR is 3.18%. Read More

What are the main product segments in the UK singleplex immunoassay market?

Main product segments include consumables, instruments, and others, with consumables valued at $12.0 Million in 2024. Read More

What types of assays are included in the UK singleplex immunoassay market?

Types of assays include protein-based, nucleic acid-based, cell-based, and others, with protein-based assays valued at $7.0 Million in 2024. Read More

What technologies are utilized in the UK singleplex immunoassay market?

Technologies include flow cytometry, fluorescence detection, and others, with fluorescence detection valued at $8.0 Million in 2024. Read More

What applications are driving the UK singleplex immunoassay market?

Applications include research & development, clinical diagnostics, and others, with clinical diagnostics valued at $10.25 Million in 2024. Read More

Who are the primary end-users of singleplex immunoassays in the UK market?

Primary end-users include pharmaceutical & biotechnology companies, hospitals & research institutes, and reference laboratories, with pharmaceutical companies valued at $8.25 Million in 2024. Read More

How does the growth of the UK singleplex immunoassay market compare to other regions?

While specific regional comparisons are not provided, the UK market is expected to grow steadily, reflecting the overall trends in the singleplex immunoassay sector. Read More

UK Singleplex Immunoassay Market

Q: Which companies are the key players in the UK singleplex immunoassay market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Merck KGaA, Bio-Rad Laboratories, Ortho Clinical Diagnostics, and PerkinElmer. Read More

ID: MRFR/HC/54373-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

UK Singleplex Immunoassay Market Research Report By Product and Service (Consumables, Instruments, Others), By Type (Protein-Based Assays, Nucleic Acid Based Assays, Cell-Based Assays, Others), By Technology (Flow Cytometry, Fluorescence Detection), By Application (Research & Development, Drug Discovery & Development, Biomarker Discovery & Validation, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Metabolism & Endocrinology Disorders, Others) and By End-user (Pharmaceutical and amp; Biotechnology Companies, Hospitals and amp; Research Institutes, Reference Laboratories, Others) Forecast to 2035

UK Singleplex Immunoassay Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)3.18%

2024 Market Size$ 14.78 Million

2025 Market Size$ 15.24 Million

2035 Market Size$ 20.85 Million

Key Players

Thermo Fisher Scientific

Abbott Laboratories

Roche Diagnostics

Siemens Healthineers

Merck KGaA

Bio-Rad Laboratories

Trends

Technological Advancements
Regulatory Support
Focus on Personalized Medicine

Opportunities

Advancements in Assay Technologies
Rising Demand for Diagnostic Testing
Growing Focus on Preventive Healthcare

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Product and Service (USD Million)
  1. 4.1.1 Consumables
  2. 4.1.2 Instruments
  3. 4.1.3 Others
2. 4.2 Life Sciences, BY Type (USD Million)
  1. 4.2.1 Protein-Based Assays
  2. 4.2.2 Nucleic Acid Based Assays
  3. 4.2.3 Cell-Based Assays
  4. 4.2.4 Others
3. 4.3 Life Sciences, BY Technology (USD Million)
  1. 4.3.1 Flow Cytometry
  2. 4.3.2 Fluorescence Detection
  3. 4.3.3 Others
4. 4.4 Life Sciences, BY Application (USD Million)
  1. 4.4.1 Research & Development
  2. 4.4.2 Clinical Diagnostics
  3. 4.4.3 Others
5. 4.5 Life Sciences, BY End-user (USD Million)
  1. 4.5.1 Pharmaceutical & Biotechnology Companies
  2. 4.5.2 Hospitals & Research Institutes
  3. 4.5.3 Reference Laboratories
  4. 4.5.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott Laboratories (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche Diagnostics (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Merck KGaA (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bio-Rad Laboratories (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Ortho Clinical Diagnostics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 PerkinElmer (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY PRODUCT AND SERVICE
3. 6.3 UK MARKET ANALYSIS BY TYPE
4. 6.4 UK MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 UK MARKET ANALYSIS BY APPLICATION
6. 6.6 UK MARKET ANALYSIS BY END-USER
7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
13. 6.13 LIFE SCIENCES, BY PRODUCT AND SERVICE, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY PRODUCT AND SERVICE, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
17. 6.17 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
18. 6.18 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
19. 6.19 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
20. 6.20 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
21. 6.21 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
22. 6.22 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Life Sciences Market Segmentation

Life Sciences By Product and Service (USD Million, 2025-2035)

Consumables
Instruments
Others

Life Sciences By Type (USD Million, 2025-2035)

Protein-Based Assays
Nucleic Acid Based Assays
Cell-Based Assays
Others

Life Sciences By Technology (USD Million, 2025-2035)

Flow Cytometry
Fluorescence Detection
Others

Life Sciences By Application (USD Million, 2025-2035)

Research & Development
Clinical Diagnostics
Others

Life Sciences By End-user (USD Million, 2025-2035)

UK Singleplex Immunoassay Market & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”